Assessment of Postdonation Outcomes in US Living Kidney Donors Using Publicly Available Data Sets

被引:11
作者
Chen, Jieming [1 ,2 ,3 ]
Bhattacharya, Sanchita [1 ,2 ]
Sirota, Marina [1 ,2 ]
Laiudompitak, Sunisa [1 ]
Schaefer, Henry [4 ]
Thomson, Elizabeth [5 ]
Wiser, Jeff [5 ]
Sarwal, Minnie M. [2 ,6 ]
Butte, Atul J. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, 550 16th St, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[3] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA
[4] ESAC Inc, Rockville, MD USA
[5] Northrop Grumman Informat Syst Hlth IT, Rockville, MD USA
[6] Univ Calif San Francisco, Dept Surg & Med, Div MultiOrgan Transplant, San Francisco, CA 94143 USA
关键词
RENAL-TRANSPLANT RECIPIENTS; RISK-STRATIFYING BIOMARKER; CALCINEURIN INHIBITOR; STEROID AVOIDANCE; RANDOMIZED-TRIAL; CLINICAL-TRIALS; VALIDATION; REJECTION; SIROLIMUS; DISEASE;
D O I
10.1001/jamanetworkopen.2019.1851
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE: There are limited resources providing postdonation conditions that can occur in living donors (LDs) of solid-organ transplant. Consequently, it is difficult to visualize and understand possible postdonation outcomes in LDs. OBJECTIVE: To assemble an open access resource that is representative of the demographic characteristics in the US national registry, maintained by the Organ Procurement and Transplantation Network and administered by the United Network for Organ Sharing, but contains more follow-up information to help to examine postdonation outcomes in LDs. DESIGN, SETTING, AND PARTICIPANTS: Cohort study in which the data for the resource and analyses stemmed from the transplant data set derived from 27 clinical studies from the ImmPort database, which is an open access repository for clinical studies. The studies included data collected from 1963 to 2016. Data from the United Network for Organ Sharing Organ Procurement and Transplantation Network national registry collected from October 1987 to March 2016 were used to determine representativeness. Data analysis took place from June 2016 to May 2018. Data from 20 ImmPort clinical studies (including clinical trials and observational studies) were curated, and a cohort of 11 263 LDs was studied, excluding deceased donors, LDs with 95% or more missing data, and studies without a complete data dictionary. The harmonization process involved the extraction of common features from each clinical study based on categories that included demographic characteristics as well as predonation and postdonation data. MAIN OUTCOMES AND MEASURES: Thirty-six postdonation events were identified, represented, and analyzed via a trajectory network analysis. RESULTS: The curated data contained 10 869 living kidney donors (median [interquartile range] age, 39 [31-48] years; 6175 [56.8%] women; and 9133 [86.6%] of European descent). A total of 9558 living kidney donors with postdonation data were analyzed. Overall, 1406 LDs (14.7%) had postdonation events. The 4 most common events were hypertension (806 [8.4%]), diabetes (190 [2.0%]), proteinuria (171 [1.8%]), and postoperative ileus (147 [1.5%]). Relatively few events (n = 269) occurred before the 2-year postdonation mark. Of the 1746 events that took place 2 years or more after donation, 1575 (90.2%) were nonsurgical; nonsurgical conditions tended to occur in the wide range of 2 to 40 years after donation (odds ratio, 38.3; 95% CI, 4.12-1956.9). CONCLUSIONS AND RELEVANCE: Most events that occurred more than 2 years after donation were nonsurgical and could occur up to 40 years after donation. Findings support the construction of a national registry for long-term monitoring of LDs and confirm the value of secondary reanalysis of clinical studies.
引用
收藏
页数:14
相关论文
共 61 条
  • [1] Complications of Living Donor Hepatic Lobectomy-A Comprehensive Report
    Abecassis, M. M.
    Fisher, R. A.
    Olthoff, K. M.
    Freise, C. E.
    Rodrigo, D. R.
    Samstein, B.
    Kam, I.
    Merion, R. M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1208 - 1217
  • [2] Standardization and Cross Validation of Alloreactive IFN ELISPOT Assays Within the Clinical Trials in Organ Transplantation Consortium
    Ashoor, I.
    Najafian, N.
    Korin, Y.
    Reed, E. F.
    Mohanakumar, T.
    Ikle, D.
    Heeger, P. S.
    Lin, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (07) : 1871 - 1879
  • [3] A Randomized Double-Blind, Placebo Controlled Trial of Steroid Withdrawal after Pediatric Renal Transplantation
    Benfield, M. R.
    Bartosh, S.
    Ikle, D.
    Warshaw, B.
    Bridges, N.
    Morrison, Y.
    Harmon, W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (01) : 81 - 88
  • [4] ImmPort, toward repurposing of open access immunological assay data for translational and clinical research
    Bhattacharya, Sanchita
    Dunn, Patrick
    Thomas, Cristel G.
    Smith, Barry
    Schaefer, Henry
    Chen, Jieming
    Hu, Zicheng
    Zalocusky, Kelly A.
    Shankar, Ravi D.
    Shen-Orr, Shai S.
    Thomson, Elizabeth
    Wiser, Jeffrey
    Butte, Atul J.
    [J]. SCIENTIFIC DATA, 2018, 5
  • [5] Gender imbalance in living organ donation
    Nikola Biller-Andorno
    [J]. Medicine, Health Care and Philosophy, 2002, 5 (2) : 199 - 203
  • [6] Bloembergen WE, 1996, J AM SOC NEPHROL, V7, P1139
  • [7] Portal vein thrombosis complicating islet transplantation in a recipient with the factor v Leiden mutation
    Brennan, DC
    Shannon, MB
    Koch, MJ
    Polonsky, KS
    Desai, N
    Shapiro, J
    [J]. TRANSPLANTATION, 2004, 78 (01) : 172 - 173
  • [8] Gene Set Enrichment Analysis Identifies Key Innate Immune Pathways in Primary Graft Dysfunction After Lung Transplantation
    Cantu, E.
    Lederer, D. J.
    Meyer, K.
    Milewski, K.
    Suzuki, Y.
    Shah, R. J.
    Diamond, J. M.
    Meyer, N. J.
    Tobias, J. W.
    Baldwin, D. A.
    Van Deerlin, V. M.
    Olthoff, K. M.
    Shaked, A.
    Christie, J. D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (07) : 1898 - 1904
  • [9] Immune Profile of Pediatric Renal Transplant Recipients following Alemtuzumab Induction
    De Serres, Sacha A.
    Mfarrej, Bechara G.
    Magee, Ciara N.
    Benitez, Fanny
    Ashoor, Isa
    Sayegh, Mohamed H.
    Harmon, William E.
    Najafian, Nader
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (01): : 174 - 182
  • [10] Complete Immunosuppression Withdrawal and Subsequent Allograft Function Among Pediatric Recipients of Parental Living Donor Liver Transplants
    Feng, Sandy
    Ekong, Udeme D.
    Lobritto, Steven J.
    Demetris, Anthony J.
    Roberts, John P.
    Rosenthal, Philip
    Alonso, Estella M.
    Philogene, Mary C.
    Ikle, David
    Poole, Katharine M.
    Bridges, Nancy D.
    Turka, Laurence A.
    Tchao, Nadia K.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (03): : 283 - 293